Related Content
Search Google Scholar for:
|
|
Science 14 August 1987:
Vol. 237. no. 4816, pp. 777 - 779
DOI: 10.1126/science.3649921
|
|
Articles
Science, Vol 237, Issue 4816, 777-779
Copyright © 1987 by American Association for the Advancement of Science
Heparin promotes the inactivation of antithrombin by neutrophil elastase
RE Jordan,
J Kilpatrick,
and
RM Nelson
Heparin is an acceleratory cofactor for antithrombin, a circulating inhibitor of blood coagulation enzymes. The presence of heparin on blood vessel walls is believed to contribute to the nonthrombogenic properties of those surfaces. In apparent opposition to this function, heparin was found to greatly accelerate the in vitro inactivation of antithrombin by neutrophil elastase. Inactivation rates in solution were potentiated several hundredfold by specific heparin fractions with anticoagulant activity. Although the data suggest that a heparin-antithrombin complex is essential for the inactivation by elastase to occur, the enzyme itself interacts tightly with heparin. These results suggest a mechanism which, if operating in vivo, could lead to a localized neutralization of the anticoagulant function of heparin at the endothelial surface.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Characterization of the Conformational Alterations, Reduced Anticoagulant Activity, and Enhanced Antiangiogenic Activity of Prelatent Antithrombin.
- B. Richard, R. Swanson, S. Schedin-Weiss, B. Ramirez, G. Izaguirre, P. G. W. Gettins, and S. T. Olson (2008)
J. Biol. Chem.
283, 14417-14429
| Abstract »
| Full Text »
| PDF »
- Mechanism by Which Exosites Promote the Inhibition of Blood Coagulation Proteases by Heparin-activated Antithrombin.
- G. Izaguirre, R. Swanson, S. M. Raja, A. R. Rezaie, and S. T. Olson (2007)
J. Biol. Chem.
282, 33609-33622
| Abstract »
| Full Text »
| PDF »
- Influence of modified ultrafiltration on coagulation, fibrinolysis and blood loss in adult cardiac surgery.
- R. G. Leyh, C. Bartels, E. Joubert-Hubner, J. F.M. Bechtel, and H. H. Sievers (2001)
Eur. J. Cardiothorac. Surg.
19, 145-151
| Abstract »
| Full Text »
| PDF »
- Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera.
- A. Falanga, M. Marchetti, V. Evangelista, A. Vignoli, M. Licini, M. Balicco, S. Manarini, G. Finazzi, C. Cerletti, and T. Barbui (2000)
Blood
96, 4261-4266
| Abstract »
| Full Text »
| PDF »
- Neutrophil Activation and Hemostatic Changes in Healthy Donors Receiving Granulocyte Colony-Stimulating Factor.
- A. Falanga, M. Marchetti, V. Evangelista, S. Manarini, E. Oldani, S. Giovanelli, M. Galbusera, C. Cerletti, and T. Barbui (1999)
Blood
93, 2506-2514
| Abstract »
| Full Text »
| PDF »
- Heparin-dependent Modification of the Reactive Center Arginine of Antithrombin and Consequent Increase in Heparin Binding Affinity.
- R. N. Pike, J. Potempa, R. Skinner, H. L. Fitton, W. T. McGraw, J. Travis, M. Owen, L. Jin, and R. W. Carrell (1997)
J. Biol. Chem.
272, 19652-19655
| Abstract »
| Full Text »
| PDF »
- Human Neutrophil Elastase Activates Human Factor V but Inactivates Thrombin-Activated Human Factor V.
- J. A. Samis, M. Garrett, R. P. Manuel, M. E. Nesheim, and A. R. Giles (1997)
Blood
90, 1065-1074
| Abstract »
| Full Text »
| PDF »
- The Suprapharmacologic Dosing of Antithrombin Concentrate for Staphylococcus Aureus-Induced Disseminated Intravascular Coagulation in Guinea Pigs: Substantial Reduction in Mortality and Morbidity.
- C. M. Kessler, Z. Tang, H. M. Jacobs, and L. M. Szymanski (1997)
Blood
89, 4393-4401
| Abstract »
| Full Text »
| PDF »
|
|
